Delivery Order SPE2DB22D1106-SPE2DB25FFAF1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,240.44 to AmerisourceBergen Drug Corp for the supply of Chlorthalidone 25 mg tablets (100-count units). This competitive award, issued on July 28, 2025, represents a firm fixed price delivery order with an ultimate completion date of July 29, 2025. The contract is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Chlorthalidone 25 mg tablets. The $3,417.69 Firm Fixed Price contract has a completion date of May 11, 2023. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The...
- This federal contract award is for the delivery of chlorthalidone 25mg tablets, a generic pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation, as a firm fixed price delivery order. The contract has a ceiling value of $2,778.31 and a performance period through March 15, 2024. No set-aside designation was used for this contract....
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is for the supply of 1,000 tablets of the medication chlorthalidone 25 mg, with a ceiling value of $1,495.68 and a completion date of June 9, 2025. The contract has a firm fixed-price pricing type and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4,565,862,399 units of the pharmaceutical product Chlorthalidone 25 mg tablets. The contract is a Firm Fixed Price Delivery Order valued at $2,568.59, with a period of performance through September 19, 2024. The contract has no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, will be providing these essential medication supplies to support...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,480.39 contract is for the supply of Chlorthalidone 25 mg tablets to support federal healthcare programs. The award has an ultimate completion date of March 31, 2023 and is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $1,338.52 and covers the delivery of 4,568,161,252 units of the medication chlorthalidone 25 mg tablets by May 7, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This federal contract award is for the delivery of 4,564,465,708 chlorthalidone 25 mg tablets (1,000s) to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 1, 2024, with a completion date of May 2, 2024. The contract type is a Delivery Order with a Firm Fixed Price of $2,791.12. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,674.50 contract is for the delivery of Chlorthalidone 25 mg tablets, a cardiovascular medication, to support military and government healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Chlorthalidone 25 mg tablets. The $18,967.65 firm-fixed-price delivery order was placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAF1Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,954.85 to AmerisourceBergen Drug Corp for the supply of Chlorthalidone 25 mg tablets in quantities of 100 units. The award, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, utilized firm fixed pricing and was not set aside for any socioeconomic category. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The pharmaceutical supply aligns with AmerisourceBergen's established role as a critical federal medical vendor specializing in generic and brand-name medications for military and veteran healthcare systems. As the incumbent prime vendor under the DLA's global pharmaceutical support vehicle, the contractor provides a comprehensive range of pharmaceutical products across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers worldwide. This transaction exemplifies the routine procurement of essential medications through the existing prime vendor framework, ensuring consistent availability of pharmaceutical supplies for federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 7/28/25 |